Scholar Rock Holding SRRK
NASDAQ SRRK
$46.81 +0.65 (+1.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Scholar Rock Holding (SRRK) Gains from Sales and Divestitures (2021 - 2026)

Updated

Scholar Rock Holding (SRRK) recorded Gains from Sales and Divestitures of -$3,000 in Q1 2026.

Analysis

Scholar Rock Holding (SRRK) Gains from Sales and Divestitures (2021 - 2026) Analysis & Trends

For FY2023, Scholar Rock Holding reported Gains from Sales and Divestitures of -$11,000.

  • Across earlier years, Gains from Sales and Divestitures came in at -$33,000 in FY2022, -$24,000 in FY2021, -$28,000 in FY2020 and $8,000 in FY2019.
  • The Q1 2026 figure is the highest quarterly Gains from Sales and Divestitures since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Scholar Rock Holding 5.69 Bn 5.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,000.00
Dec 31, 2022 -1,000.00
Mar 31, 2021 -24,000.00
API Access

Scholar Rock Holding Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SRRK&period=max&api_key=YOUR_API_KEY